News stories about "doses" in India.

CDC expedites release of 77,000 additional doses of Sanofi-AstraZeneca's RSV drug

The U.S. Centers for Disease Control and Prevention said on Thursday it has expedited the release of more than 77,000 additional doses of Sanofi (SASY.PA) and AstraZeneca's (AZN.L) respiratory syncytial virus (RSV) drug Beyfortus. Key Points

Reuters

Mission Indradhanush 5.0 in U.P.: Immunisation drive to reach 12.74L beneficiaries who missed routine doses

The goal of the drive is to extend the vaccine coverage to 12.74 lakh beneficiaries who have missed any of their routine immunisation doses. Key Points

Hindustan Times

Novavax to receive $350 mln from Canada for unused COVID shots

Novavax Inc (NVAX.O) said on Friday Canada will pay $349.6 million to settle the forfeiting of certain doses of its COVID-19 vaccine previously scheduled for delivery. Key Points

Reuters

Amid Covid surge, Tricity short of vaccine doses

Since April 1, residents of Chandigarh have been unable to receive the Covid-19 vaccine as stock ended by March 31. The local health department has reached out to the Government of India for additional vaccine supplies, but there is currently no information on when the fresh stock will arrive. Key Points

Hindustan Times

There can't be shortage of Polio vaccine; Serum Institute can make it: CEO Adar Poonawalla

Pune-based Serum Institute of India (SII) is prepared to increase production of injectable poliomyelitis vaccine (IPV) to fill the gap left by France's Sanofi closing its manufacturing plants in India. SII currently supplies half of the 20 million IPV doses to the government's immunization program and can provide additional doses with a 3-4 month notice. Adar Poonawalla, SII CEO, stated that supplying IPV to the government at current prices is unviable for most companies, but SII continues to do so as a service to the nation. Key Points

Economic Times

Covid-19 JN.1: Is your vaccine effective against the new variant?

While research on vaccine effectiveness against JN.1 is ongoing, booster doses could enhance protection by boosting the immune response, said expert. Key Points

India Today

As bulls and bears fight over Nifty, investors should focus on 6 largecap stocks with right mix of RoE & R

Once again bulls have shown that it is not easy to beat them. After a correction in September and October, November has been a month where bulls are back in control. While this fight will continue as pulls and pressure increase toward the end of the year, it would be better that as an investor stay focussed on the business you are owning. Businesses which have a track record of being able to deal with all the swings of economic cycles. It is the large cap companies with strong balance sheets, strong brands and a history of not needing frequent doses of capital which probably would be able to weather a storm and do well. Key Points

Economic Times

Covid-19: India records 47 fresh infections, active caseload at 1,655

Covid cases have declined over the last three months after a surge in infections due to XBB.1.16 Omicron variant. Key Points

mint

US CDC signs off on second Omicron-updated COVID booster for older adults

Older people and those with weakened immune systems may get a second dose of Omicron-targeting COVID-19 vaccines, the U.S. Centers for Disease Control and Prevention (CDC) said on Wednesday. Key Points

Reuters